A pair of new studies lending evidence to a frightening link between a popular blood thinner and life-threatening internal bleeding side effects may carry weight in a growing number of Pradaxa lawsuit filings.

The first study, presented at a July 1 meeting for the 2013 Congress of the International Society on Thrombosis and Haemostatis, showed that the risk for Pradaxa heart attacks and other injuries may increase as much as 70 percent in patients who took the anticoagulant manufactured by Boehringer Ingelheim, when compared to those who did not.

Another study, published in the Journal of the American College of Cardiology, found that Pradaxa could increase a patient’s risk for heart attack by 48 percent. This research compared data from Pradaxa and similar medication, warfarin.

This research analyzed data from the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) and data given to the U.S. Food and Drug Administration (FDA) by Boehringer. Even when the RE-LY figures were disregarded, researchers found the risk for Pradaxa heart attacks to be high. Out of 23,839 Pradaxa patients, 292 suffered heart attacks after taking the medication.

Higher dosages of Pradaxa put individuals at an even higher risk for this side effect, which researchers concluded to represent a causal relationship between the two. Researchers said “health care professionals and regulators should consider appropriate strategies to prevent such serious adverse drug reactions” based on their findings.

Over the past few years, the number of FDA-filed adverse event reports, not to mention Pradaxa lawsuit claims, has continued to climb. Out of 272,000 Pradaxa prescriptions issued in the U.S. between October 2010 and March 2011, 932 ‘Serious Adverse Event’ (SAE) reports were filed in the agency’s database.

These reports were filed by patients who allegedly experienced the following Pradaxa internal bleeding injuries:

  • Pradaxa bleeding in the brain (cerebral hemorrhaging)
  • Gastrointestinal (stomach) bleeding
  • Severe Pradaxa internal bleeding following a minor trauma
  • Death from serious Pradaxa internal bleeding

Pradaxa Lawsuit Filings Move Ahead in Federal Litigation

As of July 2013, at least 1,250 Pradaxa-related claims had been filed in the federal litigation underway in the U.S. District Court, Southern District of Illinois. These lawsuits allege Boehringer failed to warn the general public of the disastrous side effects that could result from use of the medication. The first bellwether trial for a federally-filed Pradaxa lawsuit has been scheduled to begin in September 2014.

File a Pradaxa Lawsuit

Given the recent research that has lent evidence to the link between Pradaxa and serious internal bleeding side effects, the time to file a claim is right now. Contact Bernstein Liebhard LLP to learn more at (877) 779-1414.

Published July 26, 2013 by